[Allele-specific inhibitors of mutant KRAS are in the focus of RASopathy consortium].
Nyíri K, Koppány G, Pálfy G, Vida I, Tóth S, Orgován Z, Ranđelović I, Baranyi M, Molnár E, Keserû MG, Tóvári J, Perczel A, Vértessy BG, Tímár J.
Nyíri K, et al. Among authors: tovari j.
Magy Onkol. 2019 Dec 9;63(4):310-323. Epub 2019 Nov 25.
Magy Onkol. 2019.
PMID: 31821386
Free article.
Hungarian.